Cat. No. 4921
Chemical Name: 4-[(5-[[4-Oxo-3-(phenylmethyl)-2-th
Biological ActivityAllosteric activator of CD11b/CD18. Increases CD11b/CD18-dependent cell adhesion to fibrinogen (EC50 = 4 μM). Decreases leukocyte motility and transendothelial migration; reduces inflammation. Also activates complement receptor 3 (CR3), and promotes CR3-dependent leukocyte adhesion to fibrinogen-coated surfaces.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Reed et al (2013) Complement receptor 3 influences Toll-like receptor 7/8-dependent inflammation. J.Biol.Chem. 288 9077. PMID: 23386618.
Maiguel et al (2011) Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease. Sci.Signal. 4 1. PMID: 21900205.
If you know of a relevant reference for Leukadherin 1 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Leukadherin 1 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Leukadherin 1, supplier, anti-inflammatory, anti-inflammatories, inflammation, leukocyte, extravasation, trans-endothelial, migration, adhesion, CD11b/CD18, activators, allosteric, integrins, Tocris Bioscience, Integrin Activator products
Find multiple products by catalog number
New Products in this Area
DR5 (TRAIL receptor) agonist; induces apoptosisBOP
Dual α9β/1α4β1 integrin inhibitor; preferentially mobilizes HSCs
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.